Sort by
Refine Your Search
-
REFINE-MS trial, a multi-centre, phase 3 study led by Professor Olga Ciccarelli and Professor Max Parmar at UCL. The trial aims to identify the optimal dosing frequency of ocrelizumab in patients with
Enter an email to receive alerts for multi-phase "https:" positions